Synthetic biology specialist Synlogic will start phase 3 testing of a drug for rare metabolic disorder phenylketonuria (PKU) next year, after reporting solid proof-of-concept data. PKU is a rare ...
Abstract: This brief proposes a novel concept named as delay output regulation (DOR) for Boolean control networks and develops a self-triggered control framework for its implementation. Unlike output ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback